Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 16:00
4.20
0.00 (0.00%)
After-Hours: 17:10
Xenetic Biosciences Total Liabilities (Quarterly) : 0.895M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.895M |
| March 31, 2026 | 0.9582M |
| December 31, 2025 | 0.968M |
| September 30, 2025 | 1.112M |
| June 30, 2025 | 0.9034M |
| March 31, 2025 | 0.6679M |
| December 31, 2024 | 0.8943M |
| September 30, 2024 | 1.009M |
| June 30, 2024 | 1.588M |
| March 31, 2024 | 0.7165M |
| December 31, 2023 | 0.8096M |
| September 30, 2023 | 1.068M |
| June 30, 2023 | 0.8713M |
| March 31, 2023 | 0.8564M |
| December 31, 2022 | 1.073M |
| September 30, 2022 | 1.051M |
| June 30, 2022 | 1.279M |
| March 31, 2022 | 1.063M |
| December 31, 2021 | 1.421M |
| September 30, 2021 | 1.122M |
| June 30, 2021 | 0.9662M |
| March 31, 2021 | 0.8158M |
| December 31, 2020 | 0.964M |
| September 30, 2020 | 0.7885M |
| June 30, 2020 | 3.706M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.426M |
| December 31, 2019 | 4.334M |
| September 30, 2019 | 4.616M |
| June 30, 2019 | 5.242M |
| March 31, 2019 | 4.938M |
| December 31, 2018 | 4.518M |
| September 30, 2018 | 4.238M |
| June 30, 2018 | 4.473M |
| March 31, 2018 | 4.658M |
| December 31, 2017 | 4.862M |
| September 30, 2017 | 5.085M |
| June 30, 2017 | 4.930M |
| March 31, 2017 | 4.928M |
| December 31, 2016 | 4.804M |
| September 30, 2016 | 7.912M |
| June 30, 2016 | 6.748M |
| March 31, 2016 | 13.30M |
| December 31, 2015 | 10.30M |
| September 30, 2015 | 9.071M |
| June 30, 2015 | 6.435M |
| March 31, 2015 | 5.833M |
| December 31, 2014 | 5.835M |
| September 30, 2014 | 5.303M |
| June 30, 2014 | 5.559M |
| March 31, 2014 | 6.057M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.968M |
| Shareholders Equity (Quarterly) | 6.073M |
| Current Ratio | 7.435 |